Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Amphastar Pharmaceuticals (DE:29A)
FRANKFURT:29A
RESEARCH TOOLSreports
Holding DE:29A?
Track your performance easily
See the Price Targets and Ratings of:
29A Analyst Ratings
Strong Buy
3 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
29A Stock 12 Month Forecast
Average Price Target
€61.07
▲(71.31% Upside)
| Highest Price Target€67.14 | Average Price Target€61.07 | Lowest Price Target€52.76 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Wells Fargo
Initiated
11/22/24
Piper Sandler
Reiterated
11/07/24
Needham
Reiterated
11/07/24
Capital One Financial
Assigned
10/18/24
Jefferies
€59.47→€52.76
Buy
47.98%
Upside
Reiterated
08/12/24
Amphastar Pharmaceuticals (AMPH) PT Lowered to $55 at JefferiesJefferies analyst Glen Santangelo lowered the price target on Amphastar Pharmaceuticals (NASDAQ: AMPH) to $55.00 (from $62.00) while maintaining a Buy rating.
Bank of America Securities
€47.96→€46.04
Hold
29.15%
Upside
Reiterated
08/08/24
Amphastar Pharmaceuticals Hold Rating Affirmed Amid Competitive Pressures and Pipeline Challenges
Ekaterina Knyazkova
Not Ranked
J.P. Morgan
€57.55
Buy
61.44%
Upside
Initiated
03/05/24
Amphastar initiated with an Overweight at JPMorganAmphastar initiated with an Overweight at JPMorgan
Best Analysts Covering Amphastar Pharmaceuticals
Which Analyst Should I Follow If I Want to Buy DE:29A and Sell After:
1 Month
xxx
Success Rate
10/18 ratings generated profit
Average Return
+2.38%
assigned a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 55.56% of your transactions generating a profit, with an average return of +2.38% per trade.
3 Months
xxx
Success Rate
9/18 ratings generated profit
Average Return
+6.27%
assigned a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +6.27% per trade.
1 Year
Success Rate
11/18 ratings generated profit
Average Return
+18.83%
assigned a buy rating 2 months ago
Copying Tim Chiang's trades and holding each position for 1 Year would result in 61.11% of your transactions generating a profit, with an average return of +18.83% per trade.
2 Years
xxx
Success Rate
12/18 ratings generated profit
Average Return
+46.16%
assigned a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 66.67% of your transactions generating a profit, with an average return of +46.16% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
29A Analyst Recommendation Trends
Rating
Jun 24
Jul 24
Aug 24
Oct 24
Nov 24
Strong Buy
6
6
4
3
2
Buy
0
0
2
3
5
Hold
5
4
3
3
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
11
10
9
9
10
Each month's total comprises the sum of three months' worth of ratings.
29A Financial Forecast
29A Stock Forecast FAQ
What is DE:29A’s average 12-month price target, according to analysts?
Based on analyst ratings, Amphastar Pharmaceuticals’s 12-month average price target is €61.07.
What is DE:29A’s upside potential, based on the analysts’ average price target?
Amphastar Pharmaceuticals has 71.31% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Amphastar Pharmaceuticals a Buy, Sell or Hold?
Amphastar Pharmaceuticals has a consensus rating of Strong Buy, which is based on 3 buy ratings, 1 hold ratings and 0 sell ratings.
What is Amphastar Pharmaceuticals’s share price target?
The average share price target for Amphastar Pharmaceuticals is €61.07. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €67.14 ,and the lowest forecast is €52.76. The average share price target represents 71.31% Increase from the current price of €35.65.
The highest analyst share price target is €67.14 ,and the lowest forecast is €52.76. The average share price target represents 71.31% Increase from the current price of €35.65.
What do analysts say about Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.
How can I buy shares of Amphastar Pharmaceuticals?
To buy shares of DE:29A, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.